Evidence map›Paper›PMID 29745376›Full record

ArticleFrontiers in pharmacology2018

Corrigendum: (-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B.

Wei Wang, Zheng-Zhu Zhang, Yan Wu, Ru-Qing Wang, Jin-Wu Chen, Jing Chen, Yan Zhang, Ya-Jun Chen, Ming Geng, Zhong-Dong Xu and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 31 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Wei WangSchool of Life Science, Hefei Normal University, Hefei, China.
Zheng-Zhu ZhangState Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University, Hefei, China.
Yan WuSchool of Life Science, Hefei Normal University, Hefei, China.
Ru-Qing WangSchool of Life Science, Hefei Normal University, Hefei, China.
Jin-Wu ChenSchool of Life Science, Hefei Normal University, Hefei, China.
Jing ChenSchool of Life Science, Hefei Normal University, Hefei, China.
Yan ZhangSchool of Life Science, Hefei Normal University, Hefei, China.
Ya-Jun ChenSchool of Life Science, Hefei Normal University, Hefei, China.
Ming GengSchool of Life Science, Hefei Normal University, Hefei, China.
Zhong-Dong XuSchool of Life Science, Hefei Normal University, Hefei, China.
Min DaiKey Laboratory of Xin'an Medicine, Ministry of Education, Anhui Key Laboratory for Research and Development of Traditional Chinese Medicine, School of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Jin-Hua LiSchool of Life Science, Hefei Normal University, Hefei, China.
Li-Long PanSchool of Medicine, Jiangnan University, Wuxi, China.
Hefei Normal University · CNAnhui Agricultural University · CNAnhui University of Traditional Chinese Medicine · CNJiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 195 in vol. 9, PMID: 29593532.].

Indexed as

atherosclerosisdyslipidemia(-)-Epigallocatechin-3-gallateinflammationtetratricopeptide repeat domain protein 39B

Identifiers

PMID29745376
PMCPMC5938370
OpenAlexW2793397537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.